BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26812695)

  • 1. Global rank tests for multiple, possibly censored, outcomes.
    Ramchandani R; Schoenfeld DA; Finkelstein DM
    Biometrics; 2016 Sep; 72(3):926-35. PubMed ID: 26812695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The appropriateness of the Wilcoxon test in ordinal data.
    Hilton JF
    Stat Med; 1996 Mar; 15(6):631-45. PubMed ID: 8731005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rank-based sample size method for multiple outcomes in clinical trials.
    Huang P; Woolson RF; O'Brien PC
    Stat Med; 2008 Jul; 27(16):3084-104. PubMed ID: 18189338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonparametric test for equality of survival medians.
    Rahbar MH; Chen Z; Jeon S; Gardiner JC; Ning J
    Stat Med; 2012 Apr; 31(9):844-54. PubMed ID: 22302559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized log-rank test for mixed interval-censored failure time data.
    Zhao Q; Sun J
    Stat Med; 2004 May; 23(10):1621-9. PubMed ID: 15122741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations.
    Matsouaka RA; Betensky RA
    Stat Med; 2015 Feb; 34(3):406-31. PubMed ID: 25393385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized pairwise comparison methods to analyze (non)prioritized composite endpoints.
    Verbeeck J; Spitzer E; de Vries T; van Es GA; Anderson WN; Van Mieghem NM; Leon MB; Molenberghs G; Tijssen J
    Stat Med; 2019 Dec; 38(30):5641-5656. PubMed ID: 31659790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flexible multi-domain test with adaptive weights and its application to clinical trials.
    Zhao Y; Yu Q; Lake SL
    Pharm Stat; 2020 May; 19(3):315-325. PubMed ID: 31886602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.
    Berry JD; Miller R; Moore DH; Cudkowicz ME; van den Berg LH; Kerr DA; Dong Y; Ingersoll EW; Archibald D
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):162-8. PubMed ID: 23323713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On non-parametric and generalized tests for the two-sample problem with location and scale change alternatives.
    Podgor MJ; Gastwirth JL
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):747-58. PubMed ID: 8023047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing a new estimator and test for the weighted all-cause hazard ratio.
    Ozga AK; Rauch G
    BMC Med Res Methodol; 2019 Jun; 19(1):118. PubMed ID: 31185922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing equality of survival functions based on both paired and unpaired censored data.
    Dallas MJ; Rao PV
    Biometrics; 2000 Mar; 56(1):154-9. PubMed ID: 10783790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Weighted Rank-Sum Procedure for Comparing Samples with Multiple Endpoints.
    Li Q; Liu A; Yu K; Yu KF
    Stat Interface; 2009 Jan; 2(2):197-201. PubMed ID: 19823699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model-informed rank test for right-censored data with intermediate states.
    Ramchandani R; Finkelstein DM; Schoenfeld DA
    Stat Med; 2015 Apr; 34(9):1454-66. PubMed ID: 25582933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.
    Potthoff RF; Halabi S
    Pharm Stat; 2015; 14(4):273-83. PubMed ID: 25894200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A class of permutation tests for stratified survival data.
    Shih JH
    Biometrics; 1999 Dec; 55(4):1156-61. PubMed ID: 11315062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of statistical issues with progression-free survival as an interval-censored time-to-event endpoint.
    Sun X; Li X; Chen C; Song Y
    J Biopharm Stat; 2013; 23(5):986-1003. PubMed ID: 23957511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome.
    Matsouaka RA; Singhal AB; Betensky RA
    Stat Methods Med Res; 2018 Aug; 27(8):2384-2400. PubMed ID: 27920364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new location-scale test based on a combination of the ideas of Levene and Lepage.
    Neuhäuser M; Leuchs AK; Ball D
    Biom J; 2011 May; 53(3):525-34. PubMed ID: 22223255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.